Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countries.
Arrieta O, Ramos-Ramírez M, Garcés-Flores H, Cabrera-Miranda LA, Gómez-García AP, Soto-Molina H, Cardona AF, Valencia-Velarde Á, Gálvez-Niño M, Guzmán-Vázquez S. Arrieta O, et al. Among authors: guzman vazquez s. Oncologist. 2024 Oct 19:oyae272. doi: 10.1093/oncolo/oyae272. Online ahead of print. Oncologist. 2024. PMID: 39427228 Free article.
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations.
Arrieta O, Catalán R, Guzmán-Vazquez S, Barrón F, Lara-Mejía L, Soto-Molina H, Ramos-Ramírez M, Flores-Estrada D, de la Garza J. Arrieta O, et al. Among authors: guzman vazquez s. BMC Cancer. 2020 Sep 1;20(1):829. doi: 10.1186/s12885-020-07329-8. BMC Cancer. 2020. PMID: 32873256 Free PMC article.
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Arrieta O, Muñoz-Montaño W, Muñiz-Hernández S, Campos S, Catalán R, Soto-Molina H, Guzmán Vázquez S, Díaz-Álvarez O, Martínez-Pacheco V, Turcott JG, Ramos-Ramírez M, Cabrera-Miranda L, Barrón F, Cardona AF. Arrieta O, et al. Among authors: guzman vazquez s. Front Oncol. 2021 Apr 20;11:641975. doi: 10.3389/fonc.2021.641975. eCollection 2021. Front Oncol. 2021. PMID: 33959504 Free PMC article.
[Economic burden assessment for the management of asthma patients at Mexico's National Institute for Respiratory Diseases].
Cano-Salas MDC, Miguel-Reyes JL, Sánchez-Trejo K, López-Estrada EDC, Salas-Hernández J, Arroyo-Rojas ME, Castañeda-Valdivia M, Escobar-Preciado M, Guzmán-Vázquez S, García-García SR, Soto-Molina H. Cano-Salas MDC, et al. Among authors: guzman vazquez s. Rev Alerg Mex. 2024 Jan 2;71(1):12-22. doi: 10.29262/ram.v71i1.1279. Rev Alerg Mex. 2024. PMID: 38683064 Spanish.
Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients.
Cano-Salas MC, Miguel-Reyes JL, López-Estrada EC, Salas-Hernández J, Arroyo-Rojas ME, Castañeda-Valdivia M, Escobar-Preciado M, Garcés-Flores H, Guzmán-Vázquez S, García-García SR, Soto-Molina H. Cano-Salas MC, et al. Among authors: guzman vazquez s. Rev Alerg Mex. 2024 Dec 23;71(4):218-228. doi: 10.29262/ram.v71i4.1295. Rev Alerg Mex. 2024. PMID: 39752263 English.
Hereditary angioedema: Patient journey approach in Mexico.
Vargas Camaño ME, Buendía López YO, Garcés Flores H, Guzmán Vázquez S. Vargas Camaño ME, et al. Among authors: guzman vazquez s. Rev Alerg Mex. 2023 Sep;70(4):121-128. doi: 10.29262/ram.v70i3.1250. Rev Alerg Mex. 2023. PMID: 37933922
Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV, Arce-Salinas CA, Guzmán-Vázquez S, Cardiel-Ríos MH. Goycochea-Robles MV, et al. Among authors: guzman vazquez s. Arch Med Res. 2007 Apr;38(3):354-9. doi: 10.1016/j.arcmed.2006.11.008. Arch Med Res. 2007. PMID: 17350489